Are you Dr. Przepiorka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1331 Union Ave
Suite 800
Memphis, TN 38104Phone+1 901-725-1785Fax+1 901-725-5264
Summary
- Dr. Donna Przepiorka, MD is an oncologist in Memphis, Tennessee. She is currently licensed to practice medicine in Tennessee.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1984 - 1987
Johns Hopkins UniversityResidency, Internal Medicine, 1980 - 1984
University of Illinois College of MedicineClass of 1980
Certifications & Licensure
TN State Medical License 2002 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsComplete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia.Robert Q Le, Donna Przepiorka, Haiyan Chen, Yuan Li Shen, E Dianne Pulte
Blood. 2024-07-11 - 13 citationsFDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.Najat Bouchkouj, Xue Lin, Xiaofei Wang, Donna Przepiorka, Zhenzhen Xu
The Oncologist. 2022-10-01 - 9 citationsFDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy.Emily Y Jen, Xin Wang, Meng Li, Hongshan Li, Shwu-Luan Lee
Clinical Cancer Research. 2022-07-15
Press Mentions
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort StudyMarch 15th, 2016
Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant RecipientsSeptember 24th, 2019
